This site is intended for healthcare professionals
Primary Hyperoxaluria Type 1
Diagnosis and management of primary hyperoxaluria type 1
Declaration of sponsorship Alnylam Pharmaceuticals

Adult with nephrocalcinosis and CKD

Declaration of sponsorship Alnylam Pharmaceuticals
Read time: 10 mins
Last updated:5th Apr 2021
Published:5th Apr 2021

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Urology resources

Welcome:

Developed by EPG Health for Medthority.com, with all content provided by Alnylam Pharmaceuticals. Learning Zone sponsored and funded by Alnylam Pharmaceuticals. Please note that this material is intended for healthcare professionals only. 

Date of preparation: November 2024 │ OXL-CEMEA-00010

© Copyright 2021